Cargando…

Retraction: Efficacy and safety of tripterygium glycosides for active moderate to severe Graves’ ophthalmopathy: a randomised, observer-masked, single-centre trial

Detalles Bibliográficos
Autores principales:	Ye, Xiaozhen, Zhao, Heng, Liu, Jun, Lu, Bin, Shao, Jiaqing, Wang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2021
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995234/ https://www.ncbi.nlm.nih.gov/pubmed/33713397 http://dx.doi.org/10.1530/EJE-20-0857z

Ejemplares similares

Efficacy and safety of tripterygium glycosides for active moderate to severe Graves’ ophthalmopathy: a randomised, observer-masked, single-centre trial
por: Ye, Xiaozhen, et al.
Publicado: (2020)

Efficacy and safety of tripterygium glycosides for Graves ophthalmopathy: A systematic review and meta-analysis
por: Liu, Xiaowei, et al.
Publicado: (2019)

Retracted: Efficacy and Safety of Glycosides of Tripterygium wilfordii Combined with Renin-Angiotensin System in the Treatment of IgA Nephropathy: A Systematic Review and Meta-Analysis
por: International, Emergency Medicine
Publicado: (2023)

Retracted: Impacts of Low-Dose Total Glycosides of Tripterygium wilfordii plus Methotrexate on Immunological Function and Inflammation Level in Patients with Rheumatoid Arthritis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: Evaluation Analysis of the Nephrotoxicity of Tripterygium wilfordii Preparations with CONSORT Harms Statement Based on Deep Learning
por: Healthcare Engineering, Journal of
Publicado: (2023)

Increased serum VEGF and b-FGF in Graves’ ophthalmopathy
por: Ye, Xiaozhen, et al.
Publicado: (2014)

Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023)

Corticosteroids in Moderate-To-Severe Graves’ Ophthalmopathy: Oral or Intravenous Therapy?
por: Penta, Laura, et al.
Publicado: (2019)

Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis
por: Lin, Na, et al.
Publicado: (2021)

Prevalence of Graves’ ophthalmopathy in patients with Graves’ disease presenting to a referral centre in north India
por: Reddy, Sagili Vijaya Bhaskar, et al.
Publicado: (2014)

Wells Syndrome Successfully Treated with Tripterygium Glycosides
por: Lu, Jiejie, et al.
Publicado: (2021)

Immunological Aspects of Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2019)

Simultaneous induction of Graves’ hyperthyroidism and Graves’ ophthalmopathy by TSHR genetic immunization in BALB/c mice
por: Xia, Nan, et al.
Publicado: (2017)

The Potential Role of Osteopontin in the Pathogenesis of Graves’ Ophthalmopathy
por: Lou, Heng, et al.
Publicado: (2021)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

FRI547 Orbital Surgery In Moderate-To-Severe Graves´Ophthalmopathy: Institutional Experience
por: Delfino, Laura, et al.
Publicado: (2023)

Retraction: Oleandrin: A Cardiac Glycosides with Potent Cytotoxicity
Publicado: (2016)

Effects of tripterygium glycosides on restenosis following endovascular treatment
por: HAN, BING, et al.
Publicado: (2016)

Proteomic Study on the Reproductive Toxicity of Tripterygium Glycosides in Rats
por: Dai, Yanlin, et al.
Publicado: (2022)

Graves' Ophthalmopathy: A Review of Immunogenetics
por: Khalilzadeh, Omid, et al.
Publicado: (2011)

Update on the medical treatment of Graves’ ophthalmopathy
por: Griepentrog, Gregory J, et al.
Publicado: (2009)

Radiotherapy in the treatment of Graves ophthalmopathy—to do it or not?
por: Zygulska, Aneta
Publicado: (2009)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
por: Chatziralli, Irini P., et al.
Publicado: (2010)

Imaging Evaluation of the Orbit in Graves Ophthalmopathy
por: SAS, T.N., et al.
Publicado: (2015)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

Orbital endoscopic decompression in Graves Ophthalmopathy
por: Lima, Wilma Terezinha Anselmo, et al.
Publicado: (2015)

Efficacy and safety of tripterygium glycosides in the treatment of hyperthyroidism: A systemic review and meta-analysis
por: Xie, Chunyan, et al.
Publicado: (2020)

Glycyrrhizic acid glycosides reduces extensive tripterygium glycosides-induced lipid deposition in hepatocytes
por: Yang, Yifei, et al.
Publicado: (2023)

The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children
por: Jin, Yan, et al.
Publicado: (2021)

Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease
por: Jarusaitiene, Dalia, et al.
Publicado: (2016)

Comparative Evaluation of Oculometric Variables in Graves’ Ophthalmopathy
por: Miot, Hélio Amante, et al.
Publicado: (2009)

Severe Grave's Ophthalmopathy–missed for many years
por: Wani, Mohd Maqbool, et al.
Publicado: (2010)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The association of carotid cavernous fistula with Graves’ ophthalmopathy
por: Celik, Ozlem, et al.
Publicado: (2013)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
por: Shi, Ting-Ting, et al.
Publicado: (2022)

Current insights of applying MRI in Graves’ ophthalmopathy
por: Song, Cheng, et al.
Publicado: (2022)

Common Immunosuppressive Monotherapy for Graves’ Ophthalmopathy: A Meta-Analysis
por: Mou, Pei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4c3ces03513rrkifpvdk0buc0u